10 Best Strong Buy Healthcare Stocks to Buy Now

7. Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Number of Hedge Fund Holders: 63

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) is one of the best strong buy healthcare stocks to buy now. On July 22, Morgan Stanley raised the firm’s price target on Neurocrine Biosciences, Inc. (NASDAQ:NBIX) to $150 from $148, keeping an Overweight rating on the shares.

The firm gave the rating ahead of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) reporting its Q2 2025 results on July 30.

Morgan Stanley expects Neurocrine Biosciences, Inc. (NASDAQ:NBIX) to report $630 million in Ingrezza sales for the quarter, aligning with expectations. It expects Crenessity sales to be around $20 million, slightly below the $23M consensus.

The firm also told investors in its preview that it continues to see “under-appreciated value in 2H and beyond.”

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) is a biopharmaceutical company with a focus on neuroscience. It is involved in the research and development, sale, and commercialization of pharmaceuticals that treat neuroendocrine, neurological, and neuropsychiatric disorders.

The company’s product portfolio includes treatments for chorea associated with Huntington’s disease, tardive dyskinesia, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids.